1![Aktuell in der Schweiz zugelassen Präparate, die gemäss Anhang 5 TAMV nicht auf Vorrat abgegeben werden dürfen (StandName CephalosprineGeneration Cefenil Ceftiocyl Eficur RTU Aktuell in der Schweiz zugelassen Präparate, die gemäss Anhang 5 TAMV nicht auf Vorrat abgegeben werden dürfen (StandName CephalosprineGeneration Cefenil Ceftiocyl Eficur RTU](https://www.pdfsearch.io/img/0ff49802ead2283e8d87323c382fd586.jpg) | Add to Reading ListSource URL: www.laburk.chLanguage: English - Date: 2016-05-25 10:06:14
|
---|
2![Technology Milestone Whitepaper EXCEDE Technology Milestone #2: Broadband Contrast Demonstration Glenn Schneider1 (PI), Julien Lozi2, Olivier Guyon, Kevin Newman (The University of Arizona) Technology Milestone Whitepaper EXCEDE Technology Milestone #2: Broadband Contrast Demonstration Glenn Schneider1 (PI), Julien Lozi2, Olivier Guyon, Kevin Newman (The University of Arizona)](https://www.pdfsearch.io/img/7c3f5c16beeefb0529e82bcc7c4ab585.jpg) | Add to Reading ListSource URL: exep.jpl.nasa.govLanguage: English - Date: 2015-02-26 13:19:08
|
---|
3![FREEDOM OF INFORMATION SUMMARY NAXCEL® Sterile Powder (ceftiofur sodium) Supplement to NADA[removed] FREEDOM OF INFORMATION SUMMARY NAXCEL® Sterile Powder (ceftiofur sodium) Supplement to NADA[removed]](https://www.pdfsearch.io/img/038530280dc3eac76d7f18884ff2f47f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
4![J/~,;,/ 1 DEPARTMENT OF HEALTH & HUMAN SERVICES[removed] J/~,;,/ 1 DEPARTMENT OF HEALTH & HUMAN SERVICES[removed]](https://www.pdfsearch.io/img/218280e897566ed35ab604956af9d034.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
5![Table 13. Other Resistance among all Ceftiofur/Ceftriaxone Resistant Salmonella (Surveillance for ESBL-producing isolates), 2011 Isolate Source Distribution (%) of MICs (µg/ml[removed] Table 13. Other Resistance among all Ceftiofur/Ceftriaxone Resistant Salmonella (Surveillance for ESBL-producing isolates), 2011 Isolate Source Distribution (%) of MICs (µg/ml[removed]](https://www.pdfsearch.io/img/0d63d67a7767d9d20f14214fea6db026.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
6![Table 30. Other Resistance among all Ceftiofur/Ceftriaxone Resistant Escherichia coli (Surveillance for ESBL-producing isolates), 2011 Antimicrobial Isolate Source (# of Isolates) Table 30. Other Resistance among all Ceftiofur/Ceftriaxone Resistant Escherichia coli (Surveillance for ESBL-producing isolates), 2011 Antimicrobial Isolate Source (# of Isolates)](https://www.pdfsearch.io/img/b75b19481497826e8da28b0f98dbe23d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
7![I DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville MD 20857 I DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville MD 20857](https://www.pdfsearch.io/img/f5eba68648e5ea6989523fba724299c7.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
8![Ceftiofur crystalline free acid Ceftiofur crystalline free acid](https://www.pdfsearch.io/img/d006f37231766ceca74bef12e0c1b84d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
9![Ceftiofur crystalline free acid Ceftiofur crystalline free acid](https://www.pdfsearch.io/img/7791e363ca9c92c39f20146c77560b44.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|